Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor α-induced mitogen-activated protein kinase and nuclear factor κB signaling pathways

Cancer Research

Volumn 60, Issue 7, 2000, Pages 2007-2017

  Remacle Bonnet, Maryse M ^a   Garrouste, Françoise L ^a   Heller, Sara ^a   André, Frédéric ^a,b   Marvaldi, Jacques L ^a   Pommier, Gilbert J ^a,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL PROTECTION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; APOPTOSIS; COLONIC NEOPLASMS; DNA FRAGMENTATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-8; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034032010     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Ashkenazi, A., and Dixit, V. M. Death receptors: signaling and modulation. Science (Washington DC), 281: 1305-1308, 1998.
2. Yuan, J. Transducing signals of life and death. Curr. Opin. Cell Biol., 9: 247-251, 1997.
3. Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997.
4. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
5. Krammer, P. H., Galle, P. R., Möller, P., and Debatin, K-M. CD95 (APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells. Adv. Cancer Res., 75: 251-273, 1998.
6. Jones, B. A., and Gores, G. J., Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am. J. Physiol., 273: G1174-G1188, 1997.
7. Liu, Z., Hsu, H., Goeddel, D. V., and Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87: 565-576, 1996.
8. 2-terminal kinase (JNK) and p38. J. Biol. Chem., 35: 22681-22692, 1998.
9. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem., 270: 16483-16486, 1995.
10. Baker, S. J., and Reddy, E. P. Modulation of life and death by the TNF receptor superfaraily. Oncogene, 17: 3261-3270, 1998.
11. Roulston, A., Reinhard, C., Amiri, P., and Williams, L. T. Early activation of c-jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α. J. Biol. Chem., 273: 10232-10239, 1998.
12. Beg, A. A., and Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Washington DC), 274: 782-784, 1996.
13. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science (Washington DC), 274: 787-789, 1996.
14. Lee, S. Y., Kaufman, D. R., Mora, A. L., Santana, A., Boothby, M., and Choi, Y. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor κB pathways. J. Exp. Med., 188: 1381-1384, 1998.
15. Nagata, S., and Golstein, P. The Fas death factor. Science (Washington DC), 267: 1449-1456, 1995.
16. Chouaih, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., and Blay, J. Y. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today, 18: 493-497, 1997.
17. Micheau, O., Solary, E., Hammann, A., Martin, F., and Dimanche-Boitrel, M-T. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity. J. Natl. Cancer Inst., 89: 783-789, 1997.
18. Raff, M. C. Social controls on cell survival and cell death. Nature (Lond.), 356: 397-400, 1992.
19. Prisco, M., Romano, G., Peruzzi, F., Valentinis, B., and Baserga, R. Insulin, and IGF-I receptors signaling in protection from apoptosis. Horm. Metab. Res., 31: 80-89, 1999.
20. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C. T., Jr. Molecular and cellular aspects of the insulin-like growth factor 1 receptor. Endocr. Rev., 16: 143-163, 1995.
21. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16: 3-34, 1995.
22. Read, L. C., Lemmey, A. B., Howarth, G. S., Martin, A. A., Tomas, F. M., and Ballard., F. J. The gastrointestinal tract is one of the most responsive target tissues for IGF-I and its potent analogs. In: E. M. Spencer (ed.), Modern Concepts of Insulin-like Growth factors, pp. 225-234. New York: Elsevier Science, 1991.
23. Drucker, D. J, Epithelial cell growth and differentiation. I. Intestinal growth factors. Am. J. Physiol., 273: G3-G6, 1997.
24. Singh, P., and Rubin, N. Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology, 105: 1218-1237, 1993.
25. Baciuchka, M., Remacle-Bonnet, M., Garrouste, F., Favre, R., Sastre, B., and Pommier, G. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: possible association with the metastatic potential of the tumor. Int. J. Cancer, 79: 460-467, 1998.
26. Ma, J., Pollak, M., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., and Stampfer, M. J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst., 91: 620-625, 1999.
27. Remacle-Bonnet, M., Garrouste, F., El Atiq, F., Roccabianca, M., Marvaldi, J., and Pommier, G. Des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells. Int. J. Cancer, 52: 910-917, 1992.
28. Remacle-Bonnet, M., Garrouste, F., El Atiq, F., Marvaldi, J., and Pommier, G. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. J. Clin. Investig., 96: 192-200, 1995.
29. André, F., Rigot, V., Remacle-Bonnet, M., Luis, J., Pommier, G., and Marvaldi, J. Protein kinases C-γ and -δ are involved in insulin-like growth factor I-induced migration of colonic epithelial cells. Gastroenterology. 116: 64-77, 1999.
30. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
31. Vermes, I., Haanen, C., and Reutelingsperger, C. P. M. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods. 180: 39-52, 1995.
32. Wen, L-P., Fahrni, J. A., Troie, S., Guan, J-L., Orth, K., and Rosen, G. D. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem., 272: 26056-26061, 1997.
33. Brancolini, C., Lazarevic, D., Rodriguez, J., and Schneider, C. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of β-catenin. J. Cell. Biol., 139: 759-771, 1997.
34. Kanety, H., Feinstein, R., Papa, M. Z., Hemi, R., and Karasik, A. Tumor necrosis factor α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). J. Biol. Chem., 270: 23780-23784, 1995.
35. Garrouste, F. L., Remacle-Bonnet, M. M., Lehmann, M. M-A., Marvaldi, J. L., and Pommier, G. J. Up-regulation of insulin/insulin-like growth factor-1 hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells. Endocrinology. 138: 2021-2032, 1997.
36. Von Reyher, U., Sträter, J., Kittstein, W., Gschwendt, M., Krammer, P. H., and Möller, P. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res., 58: 526-534, 1998.
37. Downward, J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol., 10: 262-267, 1998.
38. Franke, T. F., Kaplan, D. R., and Cantley, L. C. P13K: downstream AKTion blocks apoptosis. Cell, 88: 435-437, 1997.
39. Vlahos C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269: 5241-5248, 1994.
40. Pàrrizas, M., Saltiel, A. R., and LeRoith, D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem., 272: 154-161, 1997.
41. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase-kinase in vitro and in vivo. J. Biol. Chem., 270: 27489-27494, 1995.
42. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., and Lee, J. C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett., 364: 229-233, 1995.
43. Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., and Gerritsen, M. E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem., 272: 21096-21103, 1997.
44. Abreu-Martin, M. T., Vidrich, A., Lynch, D. H., and Targan, S. R. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen. J. Immunol., 155: 4147-4154, 1995.
45. Gross, V., Andus, T., Daig, R., Aschenbrenner, E., Schölmerich, J., and Falk, W. Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29). Gastroenterology, 108: 653-661, 1995.
46. Jung, H. C., Eckmann, L., Yang, S-K., Panja, A., Fierer, J., Morzycka-Wroblewska, E., and Kagnoff, M. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Investig., 95: 55-65, 1995.
47. 2 and tumor necrosis factor-α induce differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J. Biol. Chem., 273: 32670-32678, 1998.
48. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
49. Ossina, N. K., Cannas, A., Powers, V. C., Fitzpatrick, P. A., Knight, J. D., Gilbert, J. R., Shekhtman, L., Tomei, D., Umansky, S. R., and Kiefer, M. C. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem., 272: 16351-16357, 1997.
50. Wright, K., Kolios, G., Westwick, J., and Ward, S. G. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. J. Biol. Chem., 274: 17193-17201, 1999.
51. Haridas, V., Darnay, B. G., Natarajan, K., Heller, R., and Aggarwal, B. B. Overexpression of the p80 receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation, and c-Jun kinase activation. J. Immunol., 160: 3152-3162, 1998.
52. Liu, K. D., Gaffen, S. L., and Goldsmith, M. A. JAK/STAT signaling by cytokine receptors. Curr. Opin. Cell Biol., 10: 271-278, 1998.
53. Bertrand, F., Atfi, A., Cadoret, A., L'Allemain, G., Robin, H., Lascols, O., Capeau, J., and Cherqui, G. A role for nuclear factor κB in the antiapoptotic function of insulin. J. Biol. Chem., 271: 2931-2938, 1998.
54. Schoen, R. E., Tangen, C. M., Kuller, L. H., Burke, G. L., Cushman, M., Tracy, R. P., Dobs, A., and Savage, P. J. increased blood glucose and insulin, body size, and incident colorectal cancer. J. Natl. Cancer Inst., 91: 1147-1154, 1999.
55. D'Ambrosio, C., Valentinis, B., Prisco, M., Reiss, K., Rubini, M., and Baserga, R. Protective effect of the insulin-like growth factor 1 receptor on apoptosis induced by okadaic acid. Cancer Res., 57: 3264-3271, 1997.
56. Boehm, J. E., Chaika, O. V., and Lewis, R. E. Anti-apoptotic signaling by a colony-stimulating factor-1 receptor/insulin receptor chimera with a juxtamembrane deletion. J. Biol. Chem., 273: 7169-7176, 1998.
57. Singleton, J. R., Dixit, V. M., and Feldman, E. L. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem., 271: 31791-31794, 1996.
58. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor 1 receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997.
59. Liu, Q., Schacher, D., Hurth, C., Freund, G. G., Dantzer, R., and Kelley, K. W. Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. J. Immunol., 159: 829-837, 1997.
60. Kulik, G., and Weber, M. J. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol. Cell. Biol., 18: 6711-6718, 1998.
61. Okubo, Y., Blakesley, V. A., Stannard, B., Gutkind, S., and LeRoith, D. Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem., 273: 25961-25966, 1998.
62. Cheng, H. L., and Feldman, E. L. Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I. J. Biol. Chem., 273: 14560-14565, 1998.
63. Heck, S., Lezoualc'h, F., Engert, S., and Behl, C. Insulin-like growth factor-I-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor κB. J. Biol. Chem., 274: 9828-9835, 1999.
64. Hoshino, R., Chatani, Y., Yamori, T., Tsuruo, T., Oka, H., Yoshida, O., Shimada, Y., Ari-i, S., Wada, H., Fujimoto, J., and Kohno, M. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene, 18: 813-822, 1999.
65. Screiber, S., Nikolaus, S , and Hampe, J. Activation of nuclear factor κB in inflammatory bowel disease. Gut. 42: 477-484, 1998.
66. Sugiyama, H., Savill, J. S., Kitamura, M., Zhao, L., and Stylianou, E. Selective sensitization to tumor necrosis factor-α-induced apoptosis by blockade of NF-κB in primary glomerular mesangial cells. J. Biol. Chem., 274: 19532-19537, 1999.